drugset / Trial / NCT02909959

Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

NCT02909959

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this randomized controlled trial is to determine if a nutritional supplement containing broccoli sprout and seed extracts, a rich source of sulforaphane, is effective in reducing core symptoms of autism spectrum disorder (ASD). The study will also explore the safety and tolerability of a sulforaphane supplement in young men with ASD, as well as its effects on challenging neuropsychiatric symptoms that are commonly associated with ASD, such as hyperactivity, irritability, and repetitive movements.

Timeline

Start
2017-03-01
Primary completion
2019-05-30
Completion
2019-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sulforaphane Small molecule 3 unknown Oral
Comparator Sulforaphane Small molecule 5 unknown Oral
Comparator Sulforaphane Small molecule 6 unknown Oral
Comparator Sulforaphane Small molecule 7 unknown Oral
Comparator Sulforaphane Small molecule 8 unknown Oral

Indications